Mary Lou Robertson BA, BSW, RSW
For twenty years, Mary Lou helped health professionals to understand and navigate our fragmented benefits system in Canada. As a registered clinical social worker and later an oncology drug access specialist, she worked with thousands of patients to access millions in high cost drug therapies & health products not covered by universal health care. Her unique, patient-centered approach to benefits navigation resulted in a 98% case success rate year after year.
With a background in social policy and health systems analysis, Mary Lou makes critical connections between gaps in coverage and system inequities. In her custom training programs, she simplifies complex coverage processes and identifies the key skills needed to get patients prescription therapies in a timely manner. Her collaborative approach to training encompasses the needs of a variety of target markets – hospital clinic teams, retail and specialty pharmacy teams, pharmaceutical drug reps, case managers, reimbursement specialists, drug access navigators, etc. Her goal is to help all sectors work together collaboratively and efficiently for better patient care.
Mary Lou is a well-known advocate for timely access to prescribed therapies and is a frequent conference presenter. She is valued for her practical, direct approach to complex benefit navigation issues. She has been interviewed on drug access on CBC Radio One and several television news programs. Her work as a drug access specialist has been featured in Oncology Exchange and the Globe and Mail. Mary Lou is the recipient of Cancer Care Nova Scotia’s Annual Award of Excellence for Excellence in Patient Care (2012), the Angel in Action Award (2011) and an Award of Excellence from the Gerontology Association of NS.
“Mary Lou has been recognized informally on a national level as being a key leader in drug coverage navigation and has partnered with multiple education initiatives launched in both the academic world and with patient support networks. She always puts the patient first and strives to deliver excellence in all domains, greatly facilitating drug access across the cancer system.”Daniel Rayson, MD, FRCPC, FACP
Division of Medical Oncology
Professor of Medicine, Dalhousie University
NS Health Authority